Literature DB >> 3006951

Viral diarrhoea.

G P Davidson.   

Abstract

It is apparent from this review that great progress has been made over the past 10 years in defining the aetiology of viral diarrhoea. Rotavirus is a major cause of gastroenteritis in children, particularly during the winter months. However, if bacteriological and virological data are pooled, our current aetiological knowledge reveals that a pathogen is not detected in 20 to 30% of cases in most perennial investigations. Now that human rotavirus has been cultured, complete characterization may be possible. However, practical methods for cultivating many of the other possible viral pathogens are needed before they can be characterized completely. Meanwhile, electron microscopy, although time-consuming, cumbersome and expensive, is the only method for detecting many of the other potential viral pathogens. We have much still to learn about the epidemiology of these agents, particularly in the developing countries, their importance in causing chronic diarrhoea, how they are transmitted, and the immune responses to infection. The development of a potential rotavirus vaccine is exciting and creates the possibility of control for this devastating disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006951

Source DB:  PubMed          Journal:  Clin Gastroenterol        ISSN: 0300-5089


  2 in total

1.  Occurrence of nonspecific reactions among stool specimens tested by the Abbott TestPack rotavirus enzyme immunoassay.

Authors:  S M Lipson; G P Leonardi; R J Salo; T E Schutzbank; M H Kaplan
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.

Authors:  A P Tarver; D P Clark; G Diamond; J P Russell; H Erdjument-Bromage; P Tempst; K S Cohen; D E Jones; R W Sweeney; M Wines; S Hwang; C L Bevins
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.